- Home
- Services
- switzerland
- drug analysis and development
Show results for
Refine by
Drug Analysis And Development Services In Switzerland
8 services found
by:Solvias AG based inKaiseraugst, SWITZERLAND
The majority of drugs are administered as solids. This means that apart from the molecular structure of the active ingredient, solid-state properties significantly influence the performance of the final product. New substances with pharmaceutical activity are often weak acids or bases or may have unsuitable solid-state properties. In such cases, it may be preferable to develop the drug as a salt ...
by:Solvias AG based inKaiseraugst, SWITZERLAND
Long-term stability studies according to ICH guidelines. On-going and follow-up stability studies. Comparability studies. Stress tests, forced degradation. Photostability testing according to ICH guidelines. In-use tests, freeze-thaw cycles. Excipient/API compatibility. Interaction studies with primary packaging. Stability protocols, reports and interim reports. Stability indicated method ...
Manufactured by:Applied Pharma Research s.a. based inBalerna, SWITZERLAND
Pre-formulation development: physical and chemical characteristics of the proposed drug are analyzed to allow selection of optimal excipients and dosage forms. Formulation design: based on the product's physicochemical/release characteristics and other important aspects, a range of theoretical formulations is proposed to determine how they affect the final product's characteristics such as in ...
Manufactured by:CELONIC Group based inBasel, SWITZERLAND
ProJect Pharmaceutics* builds quality into formulation and processes and applies high-throughput predictive stability technologies (Predictive Formulation Analytics, PFA) to ensure manufacturing consistency. Using such a regulatory-compliant Quality by Design (QbD) step at an early stage will result in an accelerated and risk-mediated downstream process (DSP) development. It will also generate a ...
by:Solvias AG based inKaiseraugst, SWITZERLAND
We understand that early assessment of a protein biopharmaceutical’s stability can be invaluable, even during pre-development. For drug substances and drug products all stability aspects can be monitored including long term and accelerated stability studies, in use studies, short term temperature excursion studies, and forced degradation studies according to ICH guidelines Q5C and Q1B. ...
by:Solvias AG based inKaiseraugst, SWITZERLAND
We provide rapid and comprehensive support for your early-phase drug development process, enabling you to establish 'critical mass' – in terms of personnel and know-how – in the chemical and analytical development of complex small-molecule ...
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms. Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...